WallStSmart
CAMP

CAMP4 THERAPEUTICS CORPORATION

NASDAQ: CAMP · HEALTHCARE · BIOTECHNOLOGY

$4.01
-6.09% today

Updated 2026-04-29

Market cap
$230.55M
P/E ratio
P/S ratio
65.91x
EPS (TTM)
$-2.65
Dividend yield
52W range
$1 – $8
Volume
0.2M

CAMP4 THERAPEUTICS CORPORATION (CAMP) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$16.72M$-1.48M$13.76M$2.47M$857000.00$12.43M$16.60M$22.82M$28.64M$47.40M$25.80M$66.89M$47.74M$11.54M$28.59M$-4.22M$-38.54M$-44.16M$-45.56M$-29.55M
Capital expenditures$2.83M$1.36M$831000.00$1.07M$1.25M$1.08M$1.85M$2.13M$7.44M$4.32M$7.96M$8.34M$10.40M$21.30M$11.36M$13.30M$4.03M$678000.00$441000.00$279000.00
Depreciation
Stock-based comp$85000.00$865000.00$1.27M$1.98M$2.11M$2.38M$2.91M$2.92M$4.10M$5.85M$7.83M$9.30M$9.54M$10.67M$11.36M$11.32M$1.38M$2.91M$4.03M$4.00M
Free cash flow$13.89M$-2.83M$12.93M$1.41M$-388000.00$11.36M$14.74M$20.68M$21.21M$43.08M$17.83M$58.55M$37.34M$-9.76M$17.23M$-17.52M$-42.57M$-44.83M$-46.00M$-29.83M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash